ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 405mg powder for injection vial with diluent vial - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 405mg powder for injection vial with diluent vial AUST R: 143636Active ingredients:
olanzapine pamoate monohydrate
Dosage form: Injection, powder for
Sponsor: Pharmaco Australia Ltd
Phone: 1800201564
|
From 05 Oct 2023 to 30 Nov 2024
|
Shortage status: Current
Availability: Limited Availability
Reason: Transport / Logistic issues / Storage capacity issues
Management action: The sponsor is working to expedite the next shipment.
|